157 related articles for article (PubMed ID: 34490650)
21. A forecasting model to estimate the drop in blood supplies during the SARS-CoV-2 pandemic in Italy.
Pati I; Velati C; Mengoli C; Franchini M; Masiello F; Marano G; Veropalumbo E; Vaglio S; Piccinini V; Pupella S; Liumbruno GM
Transfus Med; 2021 Jun; 31(3):200-205. PubMed ID: 33694217
[TBL] [Abstract][Full Text] [Related]
22. Blood supply and transfusion support in southern Italy: findings during the first four weeks of the SARS-CoV-2 pandemic.
Grandone E; Mastroianno M; Caroli A; Ostuni A
Blood Transfus; 2020 May; 18(3):230-232. PubMed ID: 32453689
[No Abstract] [Full Text] [Related]
23. Management of a Hospital Transfusion Service During a Nationwide Blood Product Shortage.
O'Brien KL; Mohammed M; Uhl L
Arch Pathol Lab Med; 2018 Jul; 142(7):779-781. PubMed ID: 29939778
[No Abstract] [Full Text] [Related]
24. Transfusion medicine during COVID-19 outbreak in the hotspot of Spain.
Hernández-Maraver D; Viejo A; Kerguelén AE; Jiménez-Yuste V
Transfusion; 2020 Nov; 60(11):2762-2764. PubMed ID: 32815162
[No Abstract] [Full Text] [Related]
25. Adaptations of transfusion systems to the COVID-19 pandemic in British Columbia, Canada: Early experiences of a large tertiary care center and survey of provincial activities.
McGinnis E; Guo RJ; Marcon KM; Berry B; Coupland R; Meneghetti V; Morrison D; Onell R; Steele L; Trudeau J; Wong M; Shih AW
Transfusion; 2021 Apr; 61(4):1102-1111. PubMed ID: 33452826
[TBL] [Abstract][Full Text] [Related]
26. Transfusion Service Response to the COVID-19 Pandemic.
Gehrie E; Tormey CA; Sanford KW
Am J Clin Pathol; 2020 Aug; 154(3):280-285. PubMed ID: 32584950
[No Abstract] [Full Text] [Related]
27. [Sufficient national supply of all blood products--a pressing goal].
Högman CF
Lakartidningen; 1990 Oct; 87(40):3193-5. PubMed ID: 2232989
[No Abstract] [Full Text] [Related]
28. Needed resiliency improvements for the National Blood Supply.
Menitove JE; Reik RA; Cohn CS; Young PP; Fredrick J
Transfusion; 2021 Sep; 61(9):2772-2774. PubMed ID: 34331331
[No Abstract] [Full Text] [Related]
29. Blood use and transfusion needs at a large health care system in Washington state during the SARS-CoV-2 pandemic.
Pagano MB; Cataife G; Fertrin KY; Gernsheimer T; R Hess J; Staley E; Clark C; Senn N; Tuott E; C Tsang H
Transfusion; 2020 Dec; 60(12):2859-2866. PubMed ID: 32856307
[TBL] [Abstract][Full Text] [Related]
30. National level adjustments to the challenges of the SARS-CoV2 pandemic on blood banking operations.
Matusovits A; Nagy S; Baróti-Tóth K; Nacsa J; Lázár M; Marton I; Andrikovics H; Vokó Z; Tordai A
Transfusion; 2021 May; 61(5):1404-1411. PubMed ID: 33644858
[TBL] [Abstract][Full Text] [Related]
31. Modeling the risk of an emerging pathogen entering the Canadian blood supply.
Kleinman S; Cameron C; Custer B; Busch M; Katz L; Kralj B; Matheson I; Murphy K; Preiksaitis J; Devine D
Transfusion; 2010 Dec; 50(12):2592-606. PubMed ID: 20553433
[TBL] [Abstract][Full Text] [Related]
32. [Management of a Portuguese Blood Bank During the COVID-19 Pandemic].
Carneiro Leão D; Delgado B; Mendes-da-Silva A; Sousa M; Vaz C; Lopes M; Koch MC
Acta Med Port; 2021 Oct; 34(10):713-715. PubMed ID: 34491158
[No Abstract] [Full Text] [Related]
33. Ensuring a safe and adequate blood supply during the COVID-19 pandemic: the Moroccan National Blood Center experience.
Bouhou S; Benajiba M
Pan Afr Med J; 2020; 37():275. PubMed ID: 33598089
[TBL] [Abstract][Full Text] [Related]
34. New blood donors in times of crisis: Increased donation willingness, particularly among people at high risk for attracting SARS-CoV-2.
Spekman MLC; Ramondt S; Quee FA; Prinsze FJ; Huis In 't Veld EMJ; van den Hurk K; Merz EM
Transfusion; 2021 Jun; 61(6):1822-1829. PubMed ID: 33634876
[TBL] [Abstract][Full Text] [Related]
35. The blood supply management amid the COVID-19 outbreak.
Raturi M; Kusum A
Transfus Clin Biol; 2020 Aug; 27(3):147-151. PubMed ID: 32386966
[TBL] [Abstract][Full Text] [Related]
36. Covid 19 vaccination: Latest guidelines on blood donor deferral in India.
Bhasker B
Transfus Clin Biol; 2021 Aug; 28(3):299. PubMed ID: 34058381
[No Abstract] [Full Text] [Related]
37. Too lean: Time to build back true resiliency in the national blood supply.
Barnhard S; Klapper E; Kopko P; Tran MH; Ziman A;
Transfusion; 2021 Sep; 61(9):2768-2771. PubMed ID: 34331464
[No Abstract] [Full Text] [Related]
38. Is self-sufficiency in haemotherapies a practical or necessary goal?
Farrugia A; Cassar J
Blood Transfus; 2013 Apr; 11(2):183-92. PubMed ID: 23245724
[No Abstract] [Full Text] [Related]
39. Supply and demand for plasma-derived medicinal products - A critical reassessment amid the COVID-19 pandemic.
Hartmann J; Klein HG
Transfusion; 2020 Nov; 60(11):2748-2752. PubMed ID: 32856742
[No Abstract] [Full Text] [Related]
40. SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada.
Saeed S; Drews SJ; Pambrun C; Yi QL; Osmond L; O'Brien SF
Transfusion; 2021 Mar; 61(3):862-872. PubMed ID: 33527398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
